| Literature DB >> 35714673 |
William J Gradishar1, Meena S Moran2, Jame Abraham3, Rebecca Aft4, Doreen Agnese5, Kimberly H Allison6, Bethany Anderson7, Harold J Burstein8, Helen Chew9, Chau Dang10, Anthony D Elias11, Sharon H Giordano12, Matthew P Goetz13, Lori J Goldstein14, Sara A Hurvitz15, Steven J Isakoff16, Rachel C Jankowitz17, Sara H Javid18, Jairam Krishnamurthy19, Marilyn Leitch20, Janice Lyons3, Joanne Mortimer21, Sameer A Patel14, Lori J Pierce22, Laura H Rosenberger23, Hope S Rugo24, Amy Sitapati25, Karen Lisa Smith26, Mary Lou Smith27, Hatem Soliman28, Erica M Stringer-Reasor29, Melinda L Telli6, John H Ward30, Kari B Wisinski7, Jessica S Young31, Jennifer Burns32, Rashmi Kumar32.
Abstract
The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include recommendations for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget disease, phyllodes tumor, inflammatory breast cancer, and management of breast cancer during pregnancy. The content featured in this issue focuses on the recommendations for overall management of ductal carcinoma in situ and the workup and locoregional management of early stage invasive breast cancer. For the full version of the NCCN Guidelines for Breast Cancer, visit NCCN.org.Entities:
Mesh：
Year: 2022 PMID： 35714673 DOI： 10.6004/jnccn.2022.0030
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 12.693